These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28840514)

  • 1. Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman's syndrome and implications with hypertension.
    Pagnin E; Ravarotto V; Maiolino G; Naso E; Davis PA; Calò LA
    J Endocrinol Invest; 2018 Mar; 41(3):351-356. PubMed ID: 28840514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
    Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
    J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: Effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling.
    Ravarotto V; Pagnin E; Maiolino G; Fragasso A; Carraro G; Rossi B; Calò LA
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1245-50. PubMed ID: 26240115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
    Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
    J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
    Calò LA; Maiolino G
    J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory/profibrotic effects of aldosterone in Gitelman's syndrome, a human model opposite to hypertension.
    Ravarotto V; Simioni F; Sabbadin C; Pagnin E; Maiolino G; Armanini D; Calò LA
    J Endocrinol Invest; 2019 May; 42(5):521-526. PubMed ID: 30136149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
    Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
    High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
    Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism.
    Calò LA; Davis PA; Rossi GP
    J Hypertens; 2014 Nov; 32(11):2109-19; discussion 2119. PubMed ID: 25202962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs.
    Lutz S; Shankaranarayanan A; Coco C; Ridilla M; Nance MR; Vettel C; Baltus D; Evelyn CR; Neubig RR; Wieland T; Tesmer JJ
    Science; 2007 Dec; 318(5858):1923-7. PubMed ID: 18096806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway.
    Calò LA; Ravarotto V; Simioni F; Naso E; Marchini F; Bonfante L; Furian L; Rigotti P
    Kidney Blood Press Res; 2017; 42(4):676-685. PubMed ID: 29131070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63RhoGEF regulates auto- and paracrine signaling in cardiac fibroblasts.
    Ongherth A; Pasch S; Wuertz CM; Nowak K; Kittana N; Weis CA; Jatho A; Vettel C; Tiburcy M; Toischer K; Hasenfuss G; Zimmermann WH; Wieland T; Lutz S
    J Mol Cell Cardiol; 2015 Nov; 88():39-54. PubMed ID: 26392029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
    Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
    J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II activates the RhoA exchange factor Arhgef1 in humans.
    Carbone ML; Brégeon J; Devos N; Chadeuf G; Blanchard A; Azizi M; Pacaud P; Jeunemaître X; Loirand G
    Hypertension; 2015 Jun; 65(6):1273-8. PubMed ID: 25870189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
    Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
    Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of recruitment and allosteric activation of ARHGEF25 isoforms by the heterotrimeric G-protein Gαq.
    van Unen J; Yin T; Wu YI; Mastop M; Gadella TW; Goedhart J
    Sci Rep; 2016 Nov; 6():36825. PubMed ID: 27833100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of Gαq-protein-p63RhoGEF interaction and its regulation by RGS2.
    Bodmann EL; Rinne A; Brandt D; Lutz S; Wieland T; Grosse R; Bünemann M
    Biochem J; 2014 Feb; 458(1):131-40. PubMed ID: 24299002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere.
    Souchet M; Portales-Casamar E; Mazurais D; Schmidt S; Léger I; Javré JL; Robert P; Berrebi-Bertrand I; Bril A; Gout B; Debant A; Calmels TP
    J Cell Sci; 2002 Feb; 115(Pt 3):629-40. PubMed ID: 11861769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RhoA-specific guanine nucleotide exchange factor p63RhoGEF binds to activated Galpha(16) and inhibits the canonical phospholipase Cbeta pathway.
    Yeung WW; Wong YH
    Cell Signal; 2009 Aug; 21(8):1317-25. PubMed ID: 19332116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.